Richard M Bergenstal Selected Research

Pioglitazone (Actos)

1/2011	Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.
8/2010	Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard M Bergenstal Research Topics

Disease

76	Type 2 Diabetes Mellitus (MODY) 04/2024 - 08/2005
58	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2024 - 04/2005
42	Hypoglycemia (Reactive Hypoglycemia) 03/2024 - 08/2005
10	Hyperglycemia 05/2024 - 04/2015
10	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 02/2023 - 12/2012
9	Weight Loss (Weight Reduction) 03/2024 - 03/2008
7	Weight Gain 04/2019 - 03/2008
7	Acute Coronary Syndrome 08/2018 - 10/2011
7	Body Weight (Weight, Body) 10/2017 - 03/2008
5	Obesity 05/2024 - 06/2009
4	Overweight 05/2024 - 03/2008
4	Myocardial Infarction 11/2019 - 10/2013
4	Stroke (Strokes) 11/2019 - 01/2016
4	Pancreatitis 01/2016 - 07/2011
3	Insulin Resistance 01/2024 - 09/2009
3	Ketosis 01/2022 - 04/2015
3	Heart Failure 11/2019 - 01/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2016 - 11/2013
3	Inflammation (Inflammations) 07/2015 - 07/2011
3	Nausea 01/2011 - 05/2010
2	Gestational Diabetes (Gestational Diabetes Mellitus) 05/2024 - 05/2024
2	Diabetes Mellitus 11/2023 - 05/2012
2	Coma (Comas) 04/2021 - 12/2012
2	Diabetes Complications 01/2021 - 11/2018
2	Unstable Angina 08/2018 - 10/2013
2	Coronary Disease (Coronary Heart Disease) 01/2017 - 01/2016
2	Pain (Aches) 03/2015 - 04/2003
2	Neoplasms (Cancer) 10/2013 - 07/2011
1	Acidosis 02/2023
1	Bone Fractures (Bone Fracture) 11/2019
1	Belonephobia 01/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2016
1	Obstructive Sleep Apnea 01/2016
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2016
1	Infections 07/2015
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 06/2014

Drug/Important Bio-Agent (IBA)

76	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 09/2005
74	Insulin (Novolin)FDA Link 04/2024 - 04/2005
26	Insulin Glargine (Lantus)FDA Link 05/2023 - 03/2008
17	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 08/2005
14	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 03/2008
12	Blood Glucose (Blood Sugar)IBA 01/2022 - 04/2003
11	Exenatide (Byetta)FDA Link 04/2019 - 03/2008
9	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2016 - 04/2005
7	alogliptinIBA 08/2018 - 10/2011
6	Hemoglobins (Hemoglobin)IBA 05/2024 - 09/2005
6	Liraglutide FDA Link 01/2024 - 06/2009
6	insulin degludecIBA 05/2023 - 09/2013
6	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2022 - 06/2009
5	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2024 - 12/2012
5	Sitagliptin Phosphate (Januvia)FDA Link 01/2024 - 06/2009
5	IncretinsIBA 01/2022 - 06/2009
4	Peptides (Polypeptides)IBA 01/2022 - 06/2009
4	lixisenatideIBA 10/2017 - 11/2016
4	LY2605541IBA 01/2014 - 11/2012
3	CarbohydratesIBA 03/2024 - 04/2003
3	C-PeptideIBA 01/2024 - 04/2016
3	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 07/2011
3	InsulinsIBA 01/2021 - 12/2015
2	Sodium-Glucose Transport ProteinsIBA 03/2024 - 04/2019
2	Sodium-Glucose Transporter 2 InhibitorsIBA 02/2023 - 01/2022
2	KetonesIBA 02/2023 - 01/2022
2	Short-Acting InsulinIBA 04/2021 - 01/2016
2	omega-Chloroacetophenone (Mace)IBA 11/2019 - 01/2017
2	SuspensionsIBA 05/2015 - 07/2013
2	Pioglitazone (Actos)FDA Link 01/2011 - 08/2010
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 07/2009 - 06/2009
2	VildagliptinIBA 07/2009 - 06/2009
1	glimepiride (Amarel)FDA LinkGeneric 01/2024
1	Immune Checkpoint InhibitorsIBA 02/2023
1	DKA 9IBA 01/2022
1	tirzepatideIBA 01/2022
1	insulin icodecIBA 01/2021
1	Insulin Lispro (Humalog)FDA Link 11/2020
1	empagliflozinIBA 11/2019
1	SolutionsIBA 03/2019
1	(L)-Isomer Glucose (L-Glucose)IBA 07/2017
1	DiamondIBA 01/2017
1	Insulin Aspart (NovoLog)FDA Link 01/2017
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	AlbuminsIBA 04/2016
1	FructosamineIBA 04/2016
1	basal insulin peglisproIBA 01/2016
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2016
1	Oxygen (Dioxygen)IBA 01/2016
1	AS 8IBA 03/2015
1	Lipase (Acid Lipase)FDA Link 11/2014
1	Amylases FDA Link 11/2014
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 01/2014
1	Glucagon-Like Peptide ReceptorsIBA 11/2013
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 10/2013
1	Cardiovascular AgentsIBA 10/2013

Therapy/Procedure

40	Therapeutics 01/2024 - 08/2005
33	Glycemic Control 03/2024 - 08/2005
8	Injections 03/2024 - 07/2010
2	Drug Therapy (Chemotherapy) 03/2024 - 08/2010
1	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 02/2023
1	Ambulatory Care (Outpatient Care) 01/2021
1	Activities of Daily Living (ADL) 12/2016
1	Critical Care (Surgical Intensive Care) 07/2015